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There are health consequences of both
acute and chronic exposures ofthe skin to
reactive chemicals. Dermal exposure to
some chemicals may cause allergic sensiti-
zation such that subsequent skin contact
will result in erythema and/or edema.
Other chemicals may induce cancer at the
site of their chronic, repeated application.
Erythema and edema are temporally dis-
tinct and have not hitherto been related, as
evidenced by their independent assess-
ments when screening chemicals for toxici-
ty. The chemical induction of skin cancer
is triggered by dermal exposure to either
natural alkylating agents (electrophiles)
such as 3-propiolactone (see Table 1),
hydrolytically derived alkylating agents
such as N-methyl-N-nitroso-N'-nitro-
guanidine (MNNG), or agents such as
benzo[a]pyrene (BaP) and 7,12-dimethyl-
benz[a]anthracene (DMBA), which can be
metabolized in the skin to an electrophilic
epoxide derivative. Covalent binding of
such electrophiles to nuclear DNA can lead
to DNA mutations, and, under appropri-
ate conditions, tumors. As expected, such
agents are mutagenic in assays such as the
Salmonella test. In contrast, although the
induction ofskin sensitization depends on
interaction of the sensitizing (allergenic)
chemical with epidermal Langerhans cells
and the initiation ofspecific T-lymphocyte
responses, the nature and site ofthis inter-
action in the skin is not precisely defined.
Skin sensitization and skin carcino-
genicity almost converged in the early
1960s. In 1963, Old et al. (1) reported the
ability of BaP, DMBA, and 3-methyl-
cholanthrene to sensitize guinea pig skin,
but not mouse skin. These authors suggest-
ed that the selective immunogenic activity
was associated with the selective carcino-
genicity of these agents to mouse skin but
not to guinea pig skin. In particular, Old
et al. asserted that chemically modified
proteins triggered an immunological
response in the guinea pig that prevented
carcinogenicity.
This possible role of protein interac-
tions in carcinogenicity rapidly faded when
Brookes and Lawley (2) reported a correla-
tion between the extent ofbinding ofpoly-
cyclic aromatic hydrocarbons such as BaP
to mouse skin DNA and their respective
carcinogenic potencies to the skin. The
sensitizing activity ofBaP in the guinea pig
was confirmed in 1978 (3), but in 1987
Klemme et al. (4) demonstrated sensitizing
activity for both BaP and DMBA in the
mouse, without making reference to the
earlier negative results of Old et al. In
1967, Stevens (5) reported the results of a
study in which the ability of 44 organic
chemicals to sensitize guinea pig skin was
discussed. Three of the sensitizing chemi-
cals listed by Stevens, N-methyl-N-
nitrosourea (MNU) (6), MNNG (7), and
f-propiolactone (7), have since been
reported as skin carcinogens, but no
attempt to correlate skin carcinogenicity
and skin sensitization had been reported.
Likewise, more recently, Roberts and
Basketter (8) ex-plored the structure-activ-
ity relationship between the physicochem-
ical properties of six long-chain sulfonic
esters and their sensitizing properties to
mouse skin, but there was no discussion of
the possible skin carcinogenicity of these
agents.
A major limitation of the earlier skin
sensitization literature is the subjective
nature ofthe observations: edema and ery-
thema were scored on a scale from light
pink to bright pink (5). However, the
recently developed local lymph node assay
(9,10) has placed measurement of sensiti-
zation on an objective footing (see below),
and this led us to reevaluate the possible
relationship between the electrophilicity/
mutagenicity of chemicals and their skin-
sensitizing properties and skin carcino-
genicity. The mutagenicity of a chemical
might provide an indication ofits skin-sen-
sitizing potential, and this, in turn, might
provide a rapid and convenient indication
of its carcinogenic potential to the skin-
the definition of which is both time and
resource consuming.
Methods
All chemicals and reagents are commercial-
ly available, were of the highest available
purity, and were used as received (10).
The biological techniques we used are well
established. We determined skin-sensitiz-
ing activity by exposing the dorsum of
both ears of groups of four CBA/Ca mice
to the test chemical in olive oil/acetone
(4:1) on 3 successive days. Five days after
the initiation ofexposure, we injected mice
with tritiated thymidine (3HTdR; 30
,Ci/animal), and 5 hr later we measured
lymphocyte proliferation in the pooled
auricular lymph nodes local to the treated
ears in terms ofincorporated radioactivity.
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Table 1. Activity of 20 mutagens as skin-sensitizing agents in the local lymph node assaya
Abbr. Incorporaion of 3HTdR to ocal lymph node(teatcontd rati)
name Chemical Structure flowin eXPOue to th % souton (Wlv) shown.
[CAS Nol 0.025 0.05 0.1 0.25 0.5 1.0 2.5 5 10
MNU I- CH, 2.7 7.1 15.4
(554-93-5 NH,- I.-,N
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175e.73-4 ..N
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ENNG H NH, 1cH,CH,CH 142NN7- O."N-C-N 5.7 9.6 8.4 15.3 425774 ONz -N0
0
p-PRO 0 1.5 13.0 19.9
(57-57-41.
BP [ 3 1 17.6 19.2 27.0
D7M"B a @ t7.6 17.7 15.6 17.7
t57-97-4
CH3
1-CMP cIcH,$1 I 11.6 15.4 18.6
2M"7-CMF cH5.7 10.8 18.3 22.1
2CE CICH2CH2,H 1.2 1.0 1.6
(107.07-4
2-A.AF |
' FT HCI111.6 1.9
(53.95.3 W ~ NHcocH3
2-NF I~3uIN 2 a
(2007-5s7- NO 2 2.2 2.8
2-AAAF
06-44A4 NOCC 11.7 17.3
COCH3
0
MeCCNU II ,CH2CH21
115504 N2(.JNHC-N 0.9 1.5 0.5
CH2OH
STREP V 0
100634" STRE I OW 1 0.6 0.9 0.9 0.5, 0.6+ 0.6+
NH-C-N- -N
CH3 11.NO
0
PNN3G H 11N ,CH2CH2CH3 1.0 3.0 3.8 8.5
113010.07-4 02- N1N
MMS CH2S0,CH, 1.0 0.6 0.7 0.7 3.6
15527-3
EMS CH,803CH,CH3 0.6 0.8 1.0 0.6
(02-"0
CH 0
DMS CH0\ 3.8 6.0 5.7 29.0
177-78-11 CH,0'
CHCCH30 0
DES 0.6 1
(57-074I CH,CH,0~
0. .9 1
Abbreviations: MNU, methyl nitrosourea; ENU, ethyl nitrosourea; MNNG, N-methyl-N-nitroso-N'-
nitroguanidine; ENNG, N-ethyl-N-nitroso-N'-nitroguanidine; L-PRO, L-propiolactone; BP,
benzo[alpyrene; DMBA, dimethylbenzla]anthracene; 1-CMP, 1-chloromethylpyrene; ; 2-CMF, 2-
chloromethylfluorene; CE, chloroethanol; 2-AAF, 2-acetylaminoflurorene; 2-NF, 2-nitrofluorene; 2-AAAF,
2-(N-acetyl-N-acetoxy)aminofluorene; MeCCNU, semustine; STREP, streptozotocin; PNNG, N-propyl-N-
nitroso-N'-nitroguanidine; MMS, methyl methanesulfonate; EMS, ethyl methanesulfonate; DMS, dimethyl
sulfonate; DES, diethyl sulfonate.
aCriterion for a positive response: test/control ratio 2 3. *Tested in DMF. **Also negative when tested as
a 1.6% solution in 70% ethanol (test/control = 1.2). +Tested in ace-tone/water.
Activity in thelocal lymph node assay
is expressed as the ratio of test to control
incorporation of 3HTdR (T/C) (10). In
practice, chemicals which under these con-
ditions elicit a 3-fold or greater increase in
3HTdR incorporation relative to vehicle-
treated -controls are considered to have
skin-sensitizing potential (10). We deter-
mined mutagenicity to Salmonella typhi-
murium in the absence of auxiliary metab-
olism using strain TA98 for the aromatic
alkylating agents, strain TA1535 for the
simple alkylating agents, and strain TA98
(+S9 mix) for BaP, DMBA, 2-acety-
laminofluorene (2-AAF), and 2-nitrofluo-
rene (2-NF) (11). In two instances the
clastogenicity of established sensitizing
agents was measured in cultured mam-
malian cells. The genotoxicity data for
these two chemicals are referred to in the
text but will be published elsewhere
(Ashby, in preparation). We used a colori-
metric assay for alkylating activity employ-
ing the colorless reagent p-nitrobenzylpyri-
dine (NBP), which yields a deep-blue
product upon alkylation of its pyridine
nitrogen atom (12).
Results and Discussion
To initiate either carcinogenesis or skin
sensitization, a biologically significant level
ofDNA or protein adduction, respectively,
must be achieved in the appropriate epi-
dermal target cells within the initial few
hours of exposure. This suggests a possible
overlap of the structure-activity relation-
ships for mutagenesis, skin sensitization,
and skin carcinogenesis. For these initially
nonspecific interactions with protein and
DNA in the skin to occur, three conditions
must be met. First, the chemical, or a skin-
derived metabolite, must be electrophilic
and therefore capable of covalent reaction
with nucleophilic sites on proteins and
DNA. Second, a sufficient quantity of the
agent must penetrate the lipophilic stratum
corneum of the skin. The partition coeffi-
cient of the chemical will clearly influence
penetration; agents with low coefficients
(i.e., high water solubility) are relatively
disadvantaged. Third, once in the epider-
mis, the agent must be sufficiently reactive
to produce a biologically significant level of
protein/DNA alkylation before it is dis-
persed from the site of application and/or
metabolically detoxified. These physico-
chemical factors are subsumed in the rela-
tive alkylation index (RAI) suggested by
Roberts and Basketter (8) for alkyl sul-
fonates.
Preliminary experiments established
that the reference mouse skin carcinogens
and bacterial mutagens MNU (6), N-
ethyl-N-nitrosourea (ENU) (13), MNNG
(7), N-ethyl-N-nitroso-N'-nitroguanidine
(ENNG) (14), l-propiolactone (7), BaP
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response in the lymph node assay (Table 1).
The response observed for MNNG was the
strongest yet recorded in this assay and was
induced at dose levels similar to those used
in the skin-painting cancer bioassay. The
activity of 3-propiolactone depends on the
electrophilicity of its strained lactone ring,
which adds further structural diversity to
this set ofcarcinogens. Similar strong sensi-
tizing responses were seen for the potent
mutagens 1-chloromethyl-pyrene (1-CMP)
and 2-chloromethylfluorene (2-CMF), two
aromatic chloromethyl compounds
designed to model the ultimate carcino-
genic electrophiles formed metabolically
from polycyclic carcinogens such as BaP
and DMBA (15). Comple-menting these
strong sensitizing activities was the inactivi-
ty observed for 2-chloro-ethanol (2-CE), a
weak bacterial mutagen and probably the
most well-defined mouse skin noncarcino-
gen yet described (16). The inactivity of2-
CE as a sensitizing agent was established
under both the present standard conditions
ofthe test and when applied under the con-
ditions used in the skin-painting cancer
bioassay (a 1.6% solution in 70% ethanol).
These data therefore indicate that genotoxic
carcinogens (DNA reactive/electrophilic)
can also elicit immunogenic effects via their
inevitable parallel reactions with proteins.
The one Salmonella mutagen (2-CE) that
was unable to express its intrinsic genotoxi-
city as carcinogenicity to mouse skin was
also inactive as a sensitizing agent to mouse
skin.
The skin-sensitizing and carcinogenic
activities of BaP and DMBA depend on
their metabolism in the skin to electrophilic
epoxides, and it therefore became of inter-
est to study the sensitizing activities of the
two rodent liver carcinogens 2-AAF and 2-
NF, which are known to require complex
gut/hepatic/biliary metabolism to elec-
trophiles by enzymes, some of which are
not adequately represented in the skin. The
inactivity of2-AAF and 2-NF as sensitizing
agents at the application concentrations
studied was in contrast to the strong sensi-
tizing activity observed for the direct-acting
(S9 independent) mutagen 2-(N-acetyl-N-
acetoxy)aminofluorene (2-AAAF), a model
of the ultimate electrophile formed meta-
bolically from both 2-AAF and 2-NF
(Table 1). These data establish that some
genotoxins are prevented from eliciting bio-
logical responses in the skin due to a failure
of appropriate metabolism. It is possible
that weak sensitizing activity would be
observed for 2-AAF and 2-NF at elevated
dose levels, but the intention here was to
conduct comparative studies. The similar
sensitizing activity of the two 2-fluorenyl
derivatives, 2-AAAF and 2-CMF (Table 1),
is probably related to the similar and bulky
fluorenyl adducts they produce on proteins.
From these data, we conclude that proba-
bly all genotoxic (DNA reactive) carcino-
gens have intrinsic skin-sensitizing poten-
tial, but this potential is only realized when
the carcinogens are appropriately absorbed
across the stratum corneum and, if neces-
sary, when their metabolic conversion to an
electrophile is achieved in the skin. These
data also indicate that 2-AAAF, 2-CMF,
and 1-CMP have carcinogenic potential to
the skin.
The 13 aliphatic alkylating agents
shown in the middle panel of Figure 1 dis-
play mutagenicity to Salmonella over a 107
dose range. Although each of these agents
was already known to be mutagenic, they
have not hitherto been tested concomitant-
ly, and consequently the wide differences in
their mutagenic potencies and minimum
effective dose levels have not been known.
It is probable that this dispersion of active
dose ranges is influenced both by the differ-
ent intrinsic reactivities of the agents and
by the extent of formation and repair of
06-alkyl guanidine adducts on DNA. The
dose-response envelopes shown in Figure 1
are for mutagenicity; the shading indicates
that those agents also act as skin-sensitizing
agents (see also Table 1).
Agent
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Figure 1. Relative mutagencity to Salmonella of 20 agents tested for skin sensitization. The mutagenicity dose-response envelopes are shaded for skin-sensitiz-
ing agents (see Table 1).
Environmental Health Perspectives 64A -
. -
- 9I.I
. 9e1
Given the preponderance of immuno-
genic chemicals shown in Figure 1, muta-
gens that were inactive as sensitizing agents
obviously become of interest. The human
antitumor agent semustine (MeCCNU) is
active in slowing tumor growth by virtue
ofits ability to cross-link DNA, a property
dependent on its hydrolysis to the bifunc-
tional alkylating agent CICH2CH2N+. By
cross-linking DNA, cell replication is im-
peded (17). The most likely explanation
for the inactivity of MeCCNU as a sensi-
tizing agent is therefore that it inhibits the
necessary proliferation (9) of T-lympho-
cytes in draining lymph nodes. Consistent
with this, application of MeCCNU 1 hr
after exposure to MNNG led to a 75%
attenuation of the concomitantly observed
local lymph node assay response to
MNNG (Table 2).
The failure ofstreptozotocin to elicit a
sensitizing response is initially surprising
because this nitrosourea is a rodent car-
cinogen and mouse somatic-cell mutagen
when administered by intraperitoneal in-
jection (18). The critical structural differ-
ence between streptozotocin and MNU is
the sugar substituent on the former. The
measured log P value for streptozotocin
was -2.0 ± 0.3 (shake flask technique)
compared to MNU's value of approxi-
mately 0, and this 100-fold enhancement
of relative water solubility probably re-
duces the bioavailability of streptozotocin
by attenuating its translocation across the
lipophilic stratum corneum. In fact, strep-
tozotocin was not completely soluble in
the standard acetone/olive oil vehicle; con-
sequently, at the highest three dose levels
shown in Table 1, acetone/water (4:1) was
used as vehicle, but even in this vehicle
complete solution was not achieved at the
highest dose level. All of the other agents
in this study have log P values in the range
0-6, so a critical log P value of around -2
probably provides one key parameter for
determining skin toxicities. It is interesting
to note that exposure by intraperitoneal
injection is not impeded by the protective
lipid barrier of skin, thus explaining the
genotoxic activities of streptozotocin in
mice exposed by the parenteral route. [For
a review of the rodent genotoxicity of
streptozotocin, see Liegibel et al. (18)].
Dimethylsulfate (DMS), diethylsulfate
(DES), and the two sulfonate esters [meth-
yl methanesulfonate (MMS) and ethyl
methanesulphonate (EMS)] are interesting
because they demonstrate a wide range of
reactivities as alkylating agents. Ehrenberg
et al. (19) have measured the hydrolytic
half-lives ofthree ofthese compounds and
found DMS to have a t1/2 of 0.1 hr and
EMS and MMS to have tl12 values of4 hr
and 5 hr, respectively. These data suggest
that the relatively high dose levels ofDMS
required to elicit mutagenicity to Sal-
monella may be due to its hydrolysis before
reaction with DNA, while the similar high
dose levels required for EMS and MMS
may be due to their low intrinsic reactivity.
Likewise, although each of these alky-
lating agents gives a blue color in the NBP
test, for DMS the color can be abolished
by preincubation for 2 min with the nucle-
ophile piperidine, while the other three
compounds retain alkylating activity after
20 min of such preincubation (data not
shown). It is relevant that the weak Sal-
monella mutagen 2-CE was of such low
intrinsic alkylating activity that it required
warming with the NBP reagent in order to
develop a blue color, consistent with its
noncarcinogenicity and nonsensitizing ac-
tivity. The skin carcinogenicity of EMS
and MMS is unknown, but the present
data indicate EMS to be noncarcinogenic
and MMS to have very low carcinogenicity
to the skin. A limited skin-painting car-
cinogenicity bioassay of DMS revealed a
negative response (20), but the present sen-
sitization data indicate a carcinogenic
potential that may be realized in an ade-
quate bioassay such as that used by the
National Toxicology Program for the eval-
uation of2-CE (16). Diethysulfate and N-
propyl-N-nitroso-N'nitroguanidine are of
unknown carcinogenicity to the skin, but
based on the present sensitization data
(Table 1), we suggest that they have such
potential.
Given this correlation between the skin
carcinogenicity of a genotoxin and its
activity as a skin-sensitizing agent, the role
Table 2. Test/control (T/C) ratios of incorporation of 3HTdR in mice receiving a single application of
MNNGa
T/C ratio of3HTdR
MNNG MeCCNU incorporation into local
Test group (%w/v) (%w/v) lymph node
1 0.25 Vehicle 15.3
2 Vehicle 1.0 0.7
3 0.25 1.0 4.3
Abbreviations: MNNG, N-methyl-N-nitroso-N-nitroguanidine; MeCCNU, semustine.
aMice (rn=3) received a single application on the ears of either MNNG or vehicle alone, followed 1 hr
later by a single application of MeCCNU or vehicle. Three days later T/C ratios were determined for
pooled treatment groups.
of genotoxicity data in the prediction of
skin sensitization becomes of interest.
When screening chemicals for genotoxici-
ty, it is usual to conduct an assay for the
induction of chromosomal aberrations
(clastogenesis) on agents found to be non-
mutagenic to Salmonella. The reason for
this assay is that some chemicals are mam-
malian cell mutagens despite their inability
to mutate prokaryotic DNA (21,22). This
in turn raises the question of whether a
chemical that is nonmutagenic to Sal-
monella but which is a mammalian-cell
clastogen would have skin-sensitizing
potential.
To address this possibility, we evaluat-
ed the genotoxicity of two established sen-
sitizing agents active in the local lymph
node assay (23) but whose chemical struc-
tures (22) indicated they were unlikely to
be mutagenic to Salmonella: the oxazoli-
none 4-ethoxymethylene-2-phenyl-2-oxa-
zolidin-5-one (EPO; I, Fig. 2) and the flu-
orochrome fluorescein isiothiocynate
(FITC; II, Fig. 2). Both chemicals were
reproducibly nonmutagenic to Salmonella
but reproducibly clastogenic to cultured
mammalian cells. The Salmonella assays
were conducted using strains TA1535,
1537, 1538, 98, and 100 (11) in the pres-
ence and absence of induced rat-liver S9
mix to a high dose level of 1 mg/plate
(FITC) or 5 mg/plate (EPO). The oxazoli-
none EPO was reproducibly clastogenic to
cultured human lymphocytes (>50 pg/ml)
when treated in the absence of S9 mix for
24 hr (Mackay and Fox, unpublished
data). Fluoroscein isothiocyanate was re-
producibly clastogenic to cultured Chinese
hamster ovary cells (>400 (tg/ml) when
treated in the absence of S9 mix for 3 hr
and harvested at 20 hr (Galloway and
Armstrong, unpublished data).
Possible electrophilic sites within the
structures ofEPO and FITC that could be
responsible for their clastogenicity and sen-
sitizing activities are indicated in Figure 2,
but why such reactive centers should fail to
cause mutations in bacteria remains ob-
scure. The concept that the Michael center
in EPO and the NCS group in FITC are
reactive exclusively to proteins is an initial-
ly appealing explanation for these selective
mutagenic effects, but it remains specula-
tive.
The above findings suggest that the
mutagenicity of a chemical, as opposed to
just its activity in the Salmonella assay,
indicates carcinogenic and sensitizing
potential of the chemical to the skin.
Nonetheless, subtle differences in the
structure-activity relationships for these
three toxicities will exist. For example, all
of the methylating agents studied (MNU,
MNNG, MMS, and DMS) are more
potent sensitizing agents (Table 1) than are
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Figure 2. Chemical structure of4-ethoxymethylene-2-phenyl-2-oxazolidin-5-one (1) and fluorescein isoth-
iocyanate (11). The arrows indicate the site of possible electrophilicity on each molecule. Fluorescein
isothiocyanate is sometimes drawn in the ring-closed spiro-lactone form.
their ethylating analogues (ENU, ENNG,
EMS, and DES, respectively). This sug-
gests that methylated proteins have higher
immunogenicity, per se, compared to eth-
ylated proteins. In contrast, although
MNU and MNNG are more potent Sal-
monella mutagens than their respective
ethyl analogues (ENU and ENNG), EMS
and DES are clearly more potent mutagens
than their methyl analogues MMS and
DMS. These selective mutagenic effects are
related to differences in the nature of the
electrophilicity of the alkyl nitrosoure-
as/guanidines as compared to the alkyl sul-
fonates/sulfates. These chemical-class dif-
ferences lead to different adduction profiles
on DNA, which in turn can lead to differ-
ent and organism-specific DNA-repair/
mutagenic consequences (24). Similarly,
differences in the mitogenic properties ofa
mutagen can lead to differences in the pro-
gression of initiated cells to carcinogenesis
(25). Subtle differences are to be expected
between the structure-activity relation-
ships of mutagenesis, skin sensitization,
and dermal carcinogenicity, despite an
underlying coherence. This overall coher-
ence is illustrated by the facts that the most
potent skin-sensitizing agent described
here (MNNG) is also the most potent of
the present mutagens, and the weakest sen-
sitizing agent (MMS) is also the weakest
mutagen among those that are skin-sensi-
tizing agents (Table 1; Fig. 1).
We therefore suggest that adequate
evaluation of chemicals for genotoxicity
(21) will also yield information on skin-
sensitizing potential. In the case ofmetab-
olism-dependent genotoxins, the likeli-
hood ofthe appropriate biotransformation
occurring in the skin will have to be con-
sidered. Further, we suggest that the activi-
ty ofa genotoxin as a skin-sensitizing agent
provides strong indications of its potential
skin carcinogenicity. It must be borne in
mind, however, that relatively high dose
levels are used when assessing the skin-sen-
sitizing potential ofa chemical because this
may reflect the conditions of accidental
human exposure (10). Chronic exposure of
the skin to high, acute dose levels may not
always be possible. Consequently, consid-
eration of acute versus chronic allowable
dose levels must accompany extrapolation
of skin sensitization data to predict skin
carcinogenic potential. Nevertheless, the
dose levels used in this studywere generally
within the ranges used to establish the
potency ofthe such skin carcinogens.
As it took more than a decade to quali-
fy the initial observation that carcinogens
are mutagens (7), it would be unwise to
transmute the present correlations into
inviolable relationships. Nonetheless, it is
clear that a common structure-activity
relationship underpins genotoxicity, skin
sensitization, and skin carcinogenesis and
that in the early stages of chemically in-
duced skin carcinogenesis, adduct-related
immunogenic as well as mutagenic activity
is occurring. Such knowledge should aid
and simplify the hazard assessment of
chemicals.
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